Conversely, a recent study demonstrating that prophylactic quarterly injections with anti-VEGF therapy failed to reduce the conversion of patients with AMD from nonneovascular to neovascular undermines the assumption that sustained VEGF suppression is sufficient to prevent CNV (40). Here, VEGFA is linked to age-related macular degeneration.